| Muscular Atrophy |
1 |
0.7 |
| Sarcopenia |
0 |
0.65 |
| CT Scan |
0 |
0.61 |
| Metabolic Syndrome |
0 |
0.46 |
| Abdominal Infection |
0 |
0.4 |
| Pancreatitis |
0 |
0.4 |
| Pancreas |
0 |
0.36 |
| Scan |
0 |
0.36 |
| Chronic Pancreatitis |
0 |
0.33 |
| Biliary Disease |
0 |
0.3 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.24 |
| Endoscopic Imaging |
0 |
0.2 |
| Obesity |
0 |
0.16 |
| Fatty Liver |
0 |
0.15 |
| Liver Disease |
0 |
0.15 |
| Skeletal Myoblasts |
0 |
0.15 |
| Body Mass Index |
0 |
0.14 |
| Liver |
0 |
0.14 |
| Malnutrition |
0 |
0.14 |
| Metabolism |
0 |
0.14 |
| Muscle |
0 |
0.14 |
| Ultrasonography |
0 |
0.14 |
| Diarrhea |
0 |
0.13 |
| Pancreatic Cancer |
0 |
0.11 |
| Cardiometabolic Risk Factors |
0 |
0.08 |
| Exocrine Pancreatic Insufficiency |
0 |
0.08 |
| Lipids Management |
0 |
0.08 |
| Pain Management |
0 |
0.08 |
| Social Determinants of Health |
0 |
0.08 |
| Brachial |
0 |
0.07 |
| Cancer |
0 |
0.07 |
| Chronic Diarrhea |
0 |
0.07 |
| Clinical Management |
0 |
0.07 |
| Health Care Quality, Access, and Evaluation |
0 |
0.07 |
| Hyperlipidemia |
0 |
0.07 |
| Insulin Resistance |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Pancreatic Disease |
0 |
0.07 |
| UK Site Content |
0 |
0.07 |